Affiliation:
1. University of Kiel and University Hospital Schleswig-Holstein, Partner Site Hamburg/Kiel/Lübeck
2. University Hospital Heidelberg
3. Heilbronn University of Applied Sciences
Abstract
Abstract
Pathological remodeling of the extracellular matrix is a hallmark of cardiovascular disease, causing cardiac dysfunction by reducing ejection fraction and impaired electrical conductance, leading to arrythmias. Hence, accurate quantification of fibrosis deposition in histological sections is of extreme importance for preclinical and clinical studies. Current automatic tools do not perform well under variant conditions. Moreover, users do not have the option to evaluate data from staining methods of their choice according to their purpose. To overcome these challenges, we underline a novel machine learning-based tool (FibroSoft) and we show its feasibility in a model of cardiac hypertrophy and heart failure in mice. Our results demonstrate that FibroSoft can identify fibrosis in diseased myocardium and the obtained results are user-independent. In addition, the results acquired using our software strongly correlate to those obtained by Western blot analysis of collagen 1 expression. Additionally, we could show that this method can be used for Masson’s Trichrome and Picosirius Red stained histological images. The evaluation of our method also indicates that it can be used for any particular histology segmentation and quantification. In conclusion, our approach provides a powerful example of the feasibility of machine learning strategies to enable automatic analysis of histological images.
Publisher
Research Square Platform LLC
Reference27 articles.
1. "A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes,";Flora GD;Curr Pharm Des,2019
2. "Cardiac fibrosis - A short review of causes and therapeutic strategies,";Hinderer S;Adv Drug Deliv Rev,2019
3. "Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives,";Gonzalez A;J Am Coll Cardiol
4. "Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities,";Russo I;J Mol Cell Cardiol,2016
5. J. Diez, "Mechanisms of cardiac fibrosis in hypertension," J Clin Hypertens (Greenwich), vol. 9, no. 7, pp. 546 – 50, Jul 2007, doi: 10.1111/j.1524-6175.2007.06626.x.